CN1798845A - 黄病毒复制子包装系统 - Google Patents
黄病毒复制子包装系统 Download PDFInfo
- Publication number
- CN1798845A CN1798845A CNA200480015488XA CN200480015488A CN1798845A CN 1798845 A CN1798845 A CN 1798845A CN A200480015488X A CNA200480015488X A CN A200480015488XA CN 200480015488 A CN200480015488 A CN 200480015488A CN 1798845 A CN1798845 A CN 1798845A
- Authority
- CN
- China
- Prior art keywords
- cell
- vlp
- flavivirus
- replicon
- packing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5258—Virus-like particles
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24123—Virus like particles [VLP]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24151—Methods of production or purification of viral material
- C12N2770/24152—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
- C12N2830/005—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination repressible enhancer/promoter combination, e.g. KRAB
- C12N2830/006—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination repressible enhancer/promoter combination, e.g. KRAB tet repressible
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/42—Vector systems having a special element relevant for transcription being an intron or intervening sequence for splicing and/or stability of RNA
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2840/00—Vectors comprising a special translation-regulating system
- C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
- C12N2840/203—Vectors comprising a special translation-regulating system translation of more than one cistron having an IRES
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Plant Pathology (AREA)
- General Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Description
细胞克隆 | VLP效价*(IU/ml) |
A3 | 5.7×105 |
A8 | 2.1×108 |
E1 | 2×107 |
E5 | 5.3×104 |
诱导时间a | 电穿孔后如下时间时的VLP产量(IU/ml) | |
53小时 | 68小时 | |
0小时 | 2.1×108 | 3×107 |
16小时 | <100 | 2.9×106 |
30小时 | <100 | 5×105 |
VLP类型 | VLP效价(IU/ml) | 每3×106个细胞的总VLP产量 | ||||||
2d | 3d | 4d | 5d | 6d | 8d | 10d | ||
RNAleuMPtaKUNgagaRNAleuarepGFPbrepPACcrepPACβ-galdexp1repPACβ-galeexp2repPACβ-galeexp3 | 3.1×1071×1071.8×1081.6×108-4×1051.2×1065×106 | 5.5×1073.9×1071.9×1082.6×108---- | 3.8×1081.2×108-3.7×1081.6×1081.1×1081.6×1091.3×108 | -1.6×1072.5×1062×108---- | 2.9×108---2.2×1082.3×1081.1×1091.8×108 | 1.3×108------3.3×108 | ----1.9×108--- | 6.5×1099.5×1081.6×1095.2×1096.5×1093.4×1095.4×10101.3×1010 |
第2天 | 第4天 | 第6天 | 第8天 | |
WtNS2A/A30PNS2A/N101DNS 5/P270SNS2A/A30P/N101D | 5×1064×1064.4×1041.0×1051×104 | 1.3×1081×1081.3×1076×1071.1×105 | 1.8×1083.4×1084×1071.3×1081.2×106 | 3.3×1086×108n.d.n.d.9×106 |
Claims (29)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2003902842A AU2003902842A0 (en) | 2003-06-06 | 2003-06-06 | Flavivirus replicon packaging system |
AU2003902842 | 2003-06-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN1798845A true CN1798845A (zh) | 2006-07-05 |
Family
ID=31953883
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNA200480015488XA Pending CN1798845A (zh) | 2003-06-06 | 2004-06-07 | 黄病毒复制子包装系统 |
Country Status (8)
Country | Link |
---|---|
US (1) | US20060280757A1 (zh) |
EP (1) | EP1633877A4 (zh) |
JP (1) | JP2006526393A (zh) |
CN (1) | CN1798845A (zh) |
AU (1) | AU2003902842A0 (zh) |
CA (1) | CA2528046A1 (zh) |
NZ (1) | NZ543419A (zh) |
WO (1) | WO2004108936A1 (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102363751A (zh) * | 2011-03-24 | 2012-02-29 | 中山大学 | 登革病毒样颗粒及其制备方法与应用 |
CN111343998A (zh) * | 2017-09-11 | 2020-06-26 | 天甲生物医药有限公司 | 哺乳动物特异性的生长缺陷的虫媒病毒 |
CN113637697A (zh) * | 2021-07-13 | 2021-11-12 | 中山大学 | 一种denv-4全长感染性克隆及其构建方法 |
WO2023109975A3 (zh) * | 2021-12-17 | 2023-08-10 | 华南理工大学 | 提高基因表达的rna复制子及其应用 |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008051266A2 (en) * | 2006-02-13 | 2008-05-02 | Integral Molecular, Inc. | A dengue reporter virus and methods of making and using the same |
KR101499750B1 (ko) | 2006-02-27 | 2015-03-06 | 더 보드 오브 리전츠 오브 더 유니버시티 오브 텍사스 시스템 | 가감염성 플라비바이러스 및 이들의 용도 |
WO2009114207A2 (en) | 2008-03-14 | 2009-09-17 | Sanofi Pasteur Biologics Co. | Replication-defective flavivirus vaccines and vaccine vectors |
EP2977457B1 (en) | 2008-07-17 | 2021-09-01 | Medigen, Inc. | Idna vaccines and methods for using the same |
BE1023557B1 (fr) | 2014-02-10 | 2017-05-03 | Univercells Sa | Systeme, appareil et procede pour la production de biomolecules |
RU2729385C2 (ru) * | 2015-05-13 | 2020-08-06 | Кэлиммьюн, Инк. | Биопроизводство лентивирусных векторов |
US10799575B2 (en) | 2015-06-25 | 2020-10-13 | Technovax, Inc. | Flavivirus and alphavirus virus-like particles (VLPS) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6893866B1 (en) * | 1997-11-28 | 2005-05-17 | The Crown In The Right Of The Queensland Department Of Health | Flavivirus expression and delivery system |
EP1461441A4 (en) * | 2001-11-26 | 2006-02-22 | Univ Queensland | FEEDING SYSTEM FOR FLAVIVIRUS VACCINES |
AU2003267943C1 (en) * | 2002-02-26 | 2009-05-21 | Altravax, Inc. | Novel flavivirus antigens |
-
2003
- 2003-06-06 AU AU2003902842A patent/AU2003902842A0/en not_active Abandoned
-
2004
- 2004-06-07 CA CA002528046A patent/CA2528046A1/en not_active Abandoned
- 2004-06-07 WO PCT/AU2004/000752 patent/WO2004108936A1/en active Application Filing
- 2004-06-07 NZ NZ543419A patent/NZ543419A/en unknown
- 2004-06-07 US US10/559,146 patent/US20060280757A1/en not_active Abandoned
- 2004-06-07 JP JP2006508083A patent/JP2006526393A/ja active Pending
- 2004-06-07 EP EP04736184A patent/EP1633877A4/en not_active Withdrawn
- 2004-06-07 CN CNA200480015488XA patent/CN1798845A/zh active Pending
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102363751A (zh) * | 2011-03-24 | 2012-02-29 | 中山大学 | 登革病毒样颗粒及其制备方法与应用 |
CN111343998A (zh) * | 2017-09-11 | 2020-06-26 | 天甲生物医药有限公司 | 哺乳动物特异性的生长缺陷的虫媒病毒 |
CN113637697A (zh) * | 2021-07-13 | 2021-11-12 | 中山大学 | 一种denv-4全长感染性克隆及其构建方法 |
WO2023109975A3 (zh) * | 2021-12-17 | 2023-08-10 | 华南理工大学 | 提高基因表达的rna复制子及其应用 |
Also Published As
Publication number | Publication date |
---|---|
WO2004108936A1 (en) | 2004-12-16 |
EP1633877A4 (en) | 2007-08-22 |
AU2003902842A0 (en) | 2003-06-26 |
EP1633877A1 (en) | 2006-03-15 |
JP2006526393A (ja) | 2006-11-24 |
NZ543419A (en) | 2008-04-30 |
US20060280757A1 (en) | 2006-12-14 |
CA2528046A1 (en) | 2004-12-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2916864B1 (en) | Compositions, methods and uses for dengue virus serotype-4 constructs | |
CA2564934C (en) | Recombinant lentiviral vector for expression of a flaviviridae protein and applications thereof as a vaccine | |
CA2624130C (en) | Novel recombinant human hepatitis c virus-like particle and method for producing the same | |
US20210322535A1 (en) | Vaccines against infectious diseases caused by positive stranded rna viruses | |
JP5816614B2 (ja) | 感染性c型肝炎ウイルス高生産hcv変異体及びその利用 | |
CN1798845A (zh) | 黄病毒复制子包装系统 | |
EP1556493B1 (en) | Novel full-length genomic rna of japanese encephalitis virus, infectious jev cdna therefrom, and use thereof | |
CN1671851A (zh) | 黄病毒疫苗输送系统 | |
US8834893B2 (en) | Nucleic acid derived from hepatitis C virus and expression vector, transformed cell, and hepatitis C virus particles each prepared by using the same | |
CN104126008B (zh) | 包含来自基因型3a的丙型肝炎病毒基因组的核酸的核酸构建物 | |
CA2539457A1 (en) | Nucleic acid and gene derived from novel hcv strain and replicon-replicating cell using said gene | |
US20090017070A1 (en) | In vitro model for hepatitis c virion production | |
AU2004245578B2 (en) | Flavivirus replicon packaging system | |
JP5927185B2 (ja) | C型肝炎ウイルスj6cf株ゲノム由来の変異体レプリコン | |
WO2012133735A1 (ja) | 遺伝子型1bのC型肝炎ウイルスゲノム由来の核酸を含む核酸構築物、及び該核酸構築物が導入されたC型肝炎ウイルスゲノム複製細胞、並びに感染性C型肝炎ウイルス粒子の製造方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1094003 Country of ref document: HK |
|
ASS | Succession or assignment of patent right |
Owner name: LEIPRIQUEEN BIOTECHNOLOGY CO., LTD. Free format text: FORMER OWNER: UNIV QUEENSLAND Effective date: 20080725 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20080725 Address after: Queensland, Australia Applicant after: Bio Tech Co., Ltd. Address before: Queensland, Australia Applicant before: University of Queensland |
|
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Open date: 20060705 |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1094003 Country of ref document: HK |